Prestige BioPharmaceuticals Co Ltd (Korea)

PrestigeBio Pharmaceuticals Co Ltd (PBK) specialises in the development and production of both novel biologic agents and biosimilars. By utilizing the most advanced antibody synthesis technologies, PrestigeBio Pharmaceuticals is able to bring the highest quality antibody drugs at the most economical prices.

PBK first R&D center and GMP facility, completed in Auguest 20218 is located at Osong Medicalpolis with production capacity of 6,000 liters per annum. The second GMP will be located at Osong Biopolis with annual capacity of 25,000 liters.